Is This “6× P/E” Growth Company Actually Undervalued? $ACFN A microcap fell over 60% after Q3. But the fundamentals didn’t collapse. Price moved fast. Cash flow didn’t.

$LULU now trades at ~14.5x earnings That’s near the lowest valuation in over a decade, despite the business being larger, more global, and more cash-generative than it was back then. The market is pricing this as a broken company. The fundamentals suggest a temporary reset.

$DECK is a textbook case of valuation compression. • EPS kept rising • Price fell sharply • P/E went from ~30× to ~15× Nothing dramatic broke in earnings, but expectations did. The market repriced DECK from “growth + expansion” to “normalization.” Definitely a stock worth

$LULU today is cheaper than it’s been in years, at a time when its international growth engine is just getting started.

Very Interesting setup for $BABA right now👀

I wrote about Acorn ( $ACFN ) a few weeks ago after the stock collapsed from $30 to ~$13 on a weak Q3. The core view then was that the selloff looked driven by timing and sentiment, not deteriorating fundamentals. Today, Acorn announced a major strategic partnership, and the

$BABA isn’t a value play anymore. It’s an AI execution bet. The stock is priced on cloud growth and margins - not on China retail recovery. Upside exists, but only if AI keeps outperforming. Full breakdown on profile👇

$BRBR manufactures and sells protein shakes, power & nutrition bars... Stock is trading 66% below what they did 52-weeks ago, and hit new lows again this week. Today, up +8% after new "eat more protein" recommendations. With a cheap multiple and solid growth, this hated stock

I’m bullish on $ZZB (Zinzino). Revenue just grew ~50% to ~$350M, but the stock is still priced as if long-term growth will slow to ~15% with flat margins. The upside case is simple: • Continued scaling in the US & Asia (still very early markets) • Revenue growth stays >20% •

Protein is going mainstream 📈 Search interest keeps rising, and new dietary guidelines reinforce it. Category tailwind for brands like $BRBR

I’m bullish on $ZZB (Zinzino). Revenue just grew ~50% to ~$350M, but the stock is still priced as if long-term growth will slow to ~15% with flat margins.

$BRBR BellRing Brands stock surges 12% after Coca-Cola CEO highlights protein demand. My base case scenario still $32-35

I’m buying $ACFN when the market opens tomorrow. After Q3, the stock collapsed ~60% on timing issues. Since then: • Monitoring revenue kept growing • Free cash flow improved materially • Balance sheet stayed debt-free • And a new platform partnership expanded their long-term

$BRBR The company was so concerned about the usual class action suit threats that Board approved a $600m buyback or about 20% of its mkt cap. bellring.com/news/bellring-…

$NVO earnings in a few days. Not focused on the quarter results, but focused on what management says about 2026 growth and early uptake of the new oral GLP-1 pill. The obesity market is still expanding and the stock is priced like growth is over. If they show momentum is

A lot of stocks look cheap. Few actually are. Earnings are visible. Cash is reality. If you don’t read the cash flow statement, you’re investing in the top of the iceberg.